NG-2001

N/A

Report date: 2022/09/21 15:46:31
NME

Base Information

Drug NameNG-2001
Drug Alias NameNG-2001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoGhost Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanoGhost Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A